Clinical Trial

Timing and Dose of Fluid Deresuscitation in Critically Ill Patients

Study acronym: TIDE
Recruiting
View on ClinicalTrials.gov →
Summary
Fluid deresuscitation is an important intervention in the Intensive Care Unit (ICU). This study aims to find (1) determinants of successful deresuscitation, (2) the optimal rate (dose) of deresuscitation based on these determinants, and (3) differences in metabolic profiles for a more personalized approach of deresuscitation. This study is a multicenter, prospective, observational cohort study in critically ill patients. This study will include ICU patients who have a clinical indication for deresuscitation as set by the treating physician. Clinical, ultrasound and laboratory values will be collected and used for analysis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-28; most recent amendment 2026-01-19.
Trial Details
NCT Number NCT07275658
Lead Sponsor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborators: OLVG
Conditions Fluid Overload, Critical Care, Intensive Care, Deresuscitation
Enrollment 150 participants
Start Date 2025-10-15
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-01-21